Search alternatives:
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
10 mg » 100 mg (Expand Search), 50 mg (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), pa decreased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
10 mg » 100 mg (Expand Search), 50 mg (Expand Search)
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
Rhinorrhea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
172
Vomit-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
173
Symptoms free-days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
174
Diarrhea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
175
Nausea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
176
Cough-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
177
Dyspnea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
178
Microstructure Evolution of the Mg-5.8 Zn-0.5 Zr-1.0 Yb Alloy During Homogenization
Published 2022“…<div><p>The influence of homogenization treatment on microstructure evolution of Mg-5.8Zn-0.5Zr-1.0Yb (mass fraction, %) alloy was investigated under different annealing temperatures and holding times. …”
-
179
-
180